VI.C.1. AZT trial

Description data TOP

unitdate

{"value"=>"circa 1987-1991", "type"=>"inclusive", "certainty"=>"approximate", "normal"=>"1987/1991"}

date_inclusive_start

1987

date_inclusive_end

1991

unittitle

{"value"=>"VI.C.1. AZT trial"}

physdesc

{"value"=>"1 box", "format"=>"simple"}

note

{"type"=>"did", "value"=>"\n Sub-sub-series VI.C.1. AZT trial contains material produced by and for the Food and Drug\n Administration's review of the AZT clinical trial. Dr. Sonnabend criticized the high dosage\n prescribed.\n "}

unitid

{"type"=>"local_mss", "value"=>"513076"}

date_start

1987

date_end

1991

keydate

1987

Child components TOP

1. Food and Drug Administration (FDA) [2/1]
2. Published and near-print materials
3. Retrovir capsules NDA 19-655: Presentation for Anti-Infective Commitee meeting, May 13, 1988 by Burroughs Wellcome Company
4. Miscellaneous